{"nctId":"NCT00894556","briefTitle":"A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)","startDateStruct":{"date":"2009-06-10","type":"ACTUAL"},"conditions":["Acute Migraine"],"count":109,"armGroups":[{"label":"Treatment Sequence A","type":"EXPERIMENTAL","interventionNames":["Drug: rizatriptan","Drug: Comparator: Placebo"]},{"label":"Treatment Sequence B","type":"EXPERIMENTAL","interventionNames":["Drug: rizatriptan","Drug: Comparator: Placebo"]},{"label":"Treatment Sequence C","type":"EXPERIMENTAL","interventionNames":["Drug: rizatriptan","Drug: Comparator: Placebo"]},{"label":"Baseline Phase","type":"OTHER","interventionNames":["Drug: Comparator: Sumatriptan"]}],"interventions":[{"name":"rizatriptan","otherNames":[]},{"name":"Comparator: Placebo","otherNames":[]},{"name":"Comparator: Sumatriptan","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient has a history of migraine with or without aura for 1 year or more with 2-8 moderate or severe migraine attacks per month\n* Patient generally does not respond to treatment with sumatriptan\n* Patient of reproductive potential agrees to remain abstinent or use one method of highly effective birth control (i.e. IUD, condoms, hormonal contraceptive, diaphragm, vasectomy) for the duration of the study\n* Patient is able to complete paper diary\n\nExclusion Criteria:\n\n* Patient is pregnant or breast feeding or excepts to become pregnant during the study\n* Patient has history of mild migraine attacks or migraines that usually resolve spontaneously in less than 2 hours\n* Patient has basilar or hemiplegic migraines\n* Patient is unable to distinguish between migraine attacks from other types of headaches\n* Patient has more than 15 headache-days per month\n* Patient was greater than 50 years old at age of migraine onset\n* Patient has failed to respond to 3 or more triptans\n* Patient has a repeated history of failing to respond to or tolerate rizatriptan\n* Patient uses opioids as primary migraine therapy\n* Patient uses daily opioids\n* Patient has a history of Cerebrovascular Accident (CVA) or other significant cardiovascular disease\n* Patient has uncontrolled hypertension\n* Patient has a history of neoplastic disease\n* Patient is taking a serotonin reuptake inhibitor (SSRI or SNRI) where the dose has changed 3 months prior to screening\n* Patient has a history of drug or alcohol abuse","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Pain Relief (PR)","description":"Pain severity was rated by the participants in a paper diary. Pain severity rating scale: 0 (no pain), 1 (mild pain), 2 (moderate pain), or 3 (severe pain). Pain relief (PR) is defined as a reduction in headache severity from Grade 3/2 at baseline to Grade 1/0 post dose.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"102","spread":null},{"groupId":"OG001","value":"21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"78","spread":null}]}]}]},{"type":"SECONDARY","title":"Pain Freedom (PF)","description":"Headache pain severity, relative to the administration of study medication, was rated by the participants in a paper diary. Pain severity rating scale: 0 (no pain), 1 (mild pain), 2 (moderate pain), or 3 (severe pain). Pain freedom (PF) is defined as a reduction in headache severity from Grade 3/2 at baseline to Grade 0 (no pain) post dose.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"46","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"156","spread":null},{"groupId":"OG001","value":"87","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":102},"commonTop":["Dizziness - Baseline Phase","Dizziness - Treatment Phase","Nausea - Baseline Phase","Nausea - Treatment Phase","Chest discomfort - Baseline Phase"]}}}